{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T18:12:53Z","timestamp":1783793573364,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.clinbiochem.2019.12.015","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T11:54:32Z","timestamp":1577966072000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune response"],"prefix":"10.1016","volume":"77","author":[{"given":"Panagiota S.","family":"Filippou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie H.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoninus","family":"Soosaipillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roaa","family":"Safar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Prassas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios P.","family":"Diamandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Conner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11\u201312","key":"10.1016\/j.clinbiochem.2019.12.015_b0005","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.molimm.2010.04.020","article-title":"Serine proteases of the human immune system in health and disease","volume":"47","author":"Heutinck","year":"2010","journal-title":"Mol. Immunol."},{"issue":"2 Pt A","key":"10.1016\/j.clinbiochem.2019.12.015_b0010","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molimm.2015.04.014","article-title":"Proteolytic enzymes involved in MHC class I antigen processing: a guerrilla army that partners with the proteasome","volume":"68","author":"Lazaro","year":"2015","journal-title":"Mol. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2019.12.015_b0015","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jneuroim.2006.05.022","article-title":"Potential scope of action of tissue kallikreins in CNS immune-mediated disease","volume":"178","author":"Scarisbrick","year":"2006","journal-title":"J. Neuroimmunol."},{"issue":"45","key":"10.1016\/j.clinbiochem.2019.12.015_b0020","doi-asserted-by":"crossref","first-page":"30433","DOI":"10.1074\/jbc.R800035200","article-title":"Proteases: multifunctional enzymes in life and disease","volume":"283","author":"Lopez-Otin","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"Database","key":"10.1016\/j.clinbiochem.2019.12.015_b0025","doi-asserted-by":"crossref","first-page":"D239","DOI":"10.1093\/nar\/gkn570","article-title":"The Degradome database: mammalian proteases and diseases of proteolysis","volume":"37","author":"Quesada","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.12.015_b0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tcb.2010.12.002","article-title":"Proteolytic networks in cancer","volume":"21","author":"Mason","year":"2011","journal-title":"Trends Cell Biol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2019.12.015_b0035","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/nrc1474","article-title":"The emerging roles of human tissue kallikreins in cancer","volume":"4","author":"Borgono","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.12.015_b0040","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/10408363.2016.1154643","article-title":"Kallikrein-related peptidases (KLKs) and the hallmarks of cancer","volume":"53","author":"Filippou","year":"2016","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.12.015_b0045","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.molonc.2007.09.003","article-title":"New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family","volume":"1","author":"Emami","year":"2007","journal-title":"Mol. Oncol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.12.015_b0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1515\/bc.2010.036","article-title":"Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation","volume":"391","author":"Sotiropoulou","year":"2010","journal-title":"Biol. Chem."},{"issue":"7","key":"10.1016\/j.clinbiochem.2019.12.015_b0055","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1096\/fj.03-1212fje","article-title":"Targeting kallikrein 6 proteolysis attenuates CNS inflammatory disease","volume":"18","author":"Blaber","year":"2004","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.12.015_b0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2340\/0001555577203206","article-title":"Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitro","volume":"77","author":"Nylander-Lundqvist","year":"1997","journal-title":"Acta dermato-venereologica"},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.12.015_b0065","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1084\/jem.20082242","article-title":"Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome","volume":"206","author":"Briot","year":"2009","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.12.015_b0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jdermsci.2019.06.004","article-title":"A proinflammatory role of KLK6 protease in Netherton syndrome","volume":"95","author":"Zingkou","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.12.015_b0075","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1515\/hsz-2017-0338","article-title":"Functional interrelationships between the kallikrein-related peptidases family and the classical kinin system in the human neutrophil","volume":"399","author":"Ehrenfeld","year":"2018","journal-title":"Biol. Chem."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.12.015_b0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107213","article-title":"Autoimmune diabetes is suppressed by treatment with recombinant human tissue Kallikrein-1","volume":"9","author":"Maneva-Radicheva","year":"2014","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.12.015_b0085","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1159\/000485987","article-title":"MiRNA and mRNA profiling in systemic lupus reveals a novel set of cytokine - related miRNAs and their target genes in cases with and without renal involvement","volume":"42","author":"Jafari Ghods","year":"2017","journal-title":"Kidney Blood Press Res."},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.12.015_b0090","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1111\/j.1460-9568.2006.05021.x","article-title":"Dynamic role of kallikrein 6 in traumatic spinal cord injury","volume":"24","author":"Scarisbrick","year":"2006","journal-title":"Eur. J. Neurosci."},{"issue":"10","key":"10.1016\/j.clinbiochem.2019.12.015_b0095","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nrurol.2016.161","article-title":"Putative functions of tissue kallikrein-related peptidases in vaginal fluid","volume":"13","author":"Muytjens","year":"2016","journal-title":"Nat. Rev. Urol."},{"issue":"21","key":"10.1016\/j.clinbiochem.2019.12.015_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201600461","article-title":"Discovery of antimicrobial peptides in cervical-vaginal fluid from healthy nonpregnant women via an integrated proteome and peptidome analysis","volume":"17","author":"Muytjens","year":"2017","journal-title":"Proteomics"},{"issue":"43","key":"10.1016\/j.clinbiochem.2019.12.015_b0105","doi-asserted-by":"crossref","first-page":"32095","DOI":"10.1074\/jbc.M513138200","article-title":"Proteinase-activated receptors, targets for kallikrein signaling","volume":"281","author":"Oikonomopoulou","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.12.015_b0110","first-page":"229","article-title":"Expression of glandular kallikrein genes in lymphoid and hemopoietic tissues and cell lines","volume":"4","author":"Summers","year":"1985","journal-title":"Lymphokine Res."},{"issue":"6","key":"10.1016\/j.clinbiochem.2019.12.015_b0115","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1753425914566083","article-title":"Expression and bioregulation of the kallikrein-related peptidases family in the human neutrophil","volume":"21","author":"Lizama","year":"2015","journal-title":"Innate Immun."},{"key":"10.1016\/j.clinbiochem.2019.12.015_b0120","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12014-017-9140-6","article-title":"A new enzyme-linked immunosorbent assay (ELISA) for human free and bound kallikrein 9","volume":"14","author":"Filippou","year":"2017","journal-title":"Clin. Proteomics"},{"issue":"8","key":"10.1016\/j.clinbiochem.2019.12.015_b0125","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1373\/clinchem.2007.088104","article-title":"Distribution of 15 human kallikreins in tissues and biological fluids","volume":"53","author":"Shaw","year":"2007","journal-title":"Clin. Chem."},{"issue":"Pt 6","key":"10.1016\/j.clinbiochem.2019.12.015_b0130","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/brain\/awf142","article-title":"Activity of a newly identified serine protease in CNS demyelination","volume":"125","author":"Scarisbrick","year":"2002","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.clinbiochem.2019.12.015_b0135","doi-asserted-by":"crossref","DOI":"10.1515\/hsz-2018-0001","article-title":"Microenvironment proteinases, proteinase-activated receptor regulation, cancer and inflammation","author":"Eftekhari","year":"2018","journal-title":"Biol. Chem."},{"issue":"7","key":"10.1016\/j.clinbiochem.2019.12.015_b0140","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.4049\/jimmunol.1202999","article-title":"Induction of complement C3a receptor responses by kallikrein-related peptidase 14","volume":"191","author":"Oikonomopoulou","year":"2013","journal-title":"J. Immunol."},{"issue":"18","key":"10.1016\/j.clinbiochem.2019.12.015_b0145","doi-asserted-by":"crossref","first-page":"12743","DOI":"10.1074\/jbc.M600326200","article-title":"Human tissue kallikrein 5 is a member of a proteolytic cascade pathway involved in seminal clot liquefaction and potentially in prostate cancer progression","volume":"281","author":"Michael","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.clinbiochem.2019.12.015_b0150","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1074\/jbc.M608348200","article-title":"Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14","volume":"282","author":"Borgono","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.12.015_b0155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.0022-202X.2004.23547.x","article-title":"A proteolytic cascade of kallikreins in the stratum corneum","volume":"124","author":"Brattsand","year":"2005","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.clinbiochem.2019.12.015_b0160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nrd4534","article-title":"Unleashing the therapeutic potential of human kallikrein-related serine proteases","volume":"14","author":"Prassas","year":"2015","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"2","key":"10.1016\/j.clinbiochem.2019.12.015_b0165","first-page":"184","article-title":"The new human tissue kallikrein gene family: structure, function, and association to disease","volume":"22","author":"Yousef","year":"2001","journal-title":"Endocr. Rev."},{"issue":"11\u201312","key":"10.1016\/j.clinbiochem.2019.12.015_b0170","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00335-009-9237-y","article-title":"The canine kallikrein-related peptidases 9 and 10: structural characterization and expression in mammary cancer","volume":"20","author":"Angelopoulou","year":"2009","journal-title":"Mammalian genome: Off. J. Int. Mammalian Genome Soc."},{"key":"10.1016\/j.clinbiochem.2019.12.015_b0175","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jprot.2017.01.005","article-title":"Proteomic and peptidomic analysis of human sweat with emphasis on proteolysis","volume":"155","author":"Yu","year":"2017","journal-title":"J. Proteomics"},{"issue":"14","key":"10.1016\/j.clinbiochem.2019.12.015_b0180","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1042\/BCJ20170174","article-title":"Biochemical and functional characterization of the human tissue kallikrein 9","volume":"474","author":"Filippou","year":"2017","journal-title":"Biochem. J."},{"key":"10.1016\/j.clinbiochem.2019.12.015_b0185","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-8722-3-7","article-title":"Ovarian cancer immunotherapy: opportunities, progresses and challenges","volume":"3","author":"Liu","year":"2010","journal-title":"J. Hematol. Oncol."},{"issue":"11","key":"10.1016\/j.clinbiochem.2019.12.015_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186847","article-title":"Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer","volume":"12","author":"Geng","year":"2017","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.clinbiochem.2019.12.015_b0195","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nri3689","article-title":"Follicular dendritic cells: dynamic antigen libraries","volume":"14","author":"Heesters","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.12.015_b0200","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1515\/hsz-2014-0141","article-title":"Differential expression of multiple kallikreins in a viral model of multiple sclerosis points to unique roles in the innate and adaptive immune response","volume":"395","author":"Panos","year":"2014","journal-title":"Biol. Chem."},{"issue":"46","key":"10.1016\/j.clinbiochem.2019.12.015_b0205","doi-asserted-by":"crossref","first-page":"E9942","DOI":"10.1073\/pnas.1707658114","article-title":"The immunopeptidomic landscape of ovarian carcinomas","volume":"114","author":"Schuster","year":"2017","journal-title":"PNAS"},{"issue":"8","key":"10.1016\/j.clinbiochem.2019.12.015_b0210","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1373\/clinchem.2005.049692","article-title":"Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids","volume":"51","author":"Obiezu","year":"2005","journal-title":"Clin. Chem."},{"issue":"14","key":"10.1016\/j.clinbiochem.2019.12.015_b0215","first-page":"3958","article-title":"Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer","volume":"63","author":"Yousef","year":"2003","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.clinbiochem.2019.12.015_b0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0009-9120(00)00145-4","article-title":"Immunofluorometric assay of human kallikrein 6 (zyme\/protease M\/neurosin) and preliminary clinical applications","volume":"33","author":"Diamandis","year":"2000","journal-title":"Clin. Biochem."},{"issue":"9","key":"10.1016\/j.clinbiochem.2019.12.015_b0225","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1515\/hsz-2014-0142","article-title":"Kallikrein-related peptidase 7 (KLK7) is a proliferative factor that is aberrantly expressed in human colon cancer","volume":"395","author":"Walker","year":"2014","journal-title":"Biol. Chem."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.12.015_b0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1373\/49.1.87","article-title":"Human kallikrein 8: immunoassay development and identification in tissue extracts and biological fluids","volume":"49","author":"Kishi","year":"2003","journal-title":"Clin. Chem."},{"issue":"8","key":"10.1016\/j.clinbiochem.2019.12.015_b0235","first-page":"2372","article-title":"Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma","volume":"7","author":"Luo","year":"2001","journal-title":"Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.12.015_b0240","first-page":"295","article-title":"Human kallikrein 11: a new biomarker of prostate and ovarian carcinoma","volume":"62","author":"Diamandis","year":"2002","journal-title":"Cancer Res."},{"issue":"13","key":"10.1016\/j.clinbiochem.2019.12.015_b0245","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/pros.20596","article-title":"Human kallikrein-related peptidase 12: antibody generation and immunohistochemical localization in prostatic tissues","volume":"67","author":"Memari","year":"2007","journal-title":"Prostate"},{"issue":"1","key":"10.1016\/j.clinbiochem.2019.12.015_b0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1373\/49.1.77","article-title":"Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay","volume":"49","author":"Kapadia","year":"2003","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2019.12.015_b0255","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.clinbiochem.2018.06.017","article-title":"Expression profile of human tissue kallikrein 15 provides preliminary insights into its roles in the prostate and testis","volume":"59","author":"Filippou","year":"2018","journal-title":"Clin. Biochem."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019310112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912019310112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:09:48Z","timestamp":1762114188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912019310112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":51,"alternative-id":["S0009912019310112"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.12.015","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kallikrein-related peptidases protein expression in lymphoid tissues suggests potential implications in immune response","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2019.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}